Perrigo Company News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.11.24	Perrigo Company Posts Loss From Cont. Ops. In Q3; Reaffirms FY24 Adj. EPS Outlook (RTTNews)
06.11.24	Perrigo Company Plc Q3 Earnings Summary (RTTNews)
12.09.24	Perrigo Prices Senior Notes Offering Due 2032 Through Finance Subsidiary (RTTNews)
09.08.24	Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula (RTTNews)
02.08.24	Perrigo Reaffirms FY24 Adj. EPS Guidance; Updates Sales Outlook (RTTNews)
02.08.24	Perrigo Company Plc Q2 Earnings Summary (RTTNews)
07.05.24	Perrigo Reaffirms 2024 Outlook - Update (RTTNews)
07.05.24	Perrigo Company plc Q1 Earnings Summary (RTTNews)
25.04.24	Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln (RTTNews)
04.03.24	Perrigo Initiates Shipments Of Opill To Retailers Nationwide (RTTNews)
27.02.24	Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update (RTTNews)
27.02.24	Perrigo Guides FY24 Well Below Estimates - Update (RTTNews)
27.02.24	Perrigo Company plc Q4 Earnings Summary (RTTNews)
07.11.23	Perrigo Cuts FY23 Adj. Earnings View Below Market; Stock Down In Premarket - Update (RTTNews)
07.11.23	Perrigo Company plc Q3 Earnings Summary (RTTNews)
24.10.23	Perrigo to Release Third Quarter 2023 Financial Results on November 7, 2023 (PR Newswire)
08.08.23	Perrigo Company plc Q2 Earnings Summary (RTTNews)
02.08.23	PERRIGO ANNOUNCES QUARTERLY DIVIDEND (PR Newswire)
13.07.23	FDA Approves Perrigo's Opill, The First Over-the-counter Birth Control Pill (RTTNews)
08.06.23	Perrigo Appoints Patrick Lockwood-Taylor As President And CEO (RTTNews)
16.05.23	COUNTRY STAR MITCHELL TENPENNY AND PREVACID ANNOUNCE "BEAT THE BURN" - A LIVE TIK TOK CONCERT TO SING AWAY STRESS (PR Newswire)
16.05.23	Perrigo: FDA Approves Nicotine Coated Mint Lozenges (RTTNews)
11.05.23	FDA Panel Votes In Favor Of Perrigo's Birth Control Pill For OTC Use (RTTNews)
09.05.23	Perrigo: Murray Kessler To Retire; Delivers Double-digit Top Line Growth In Q1, Reaffirms Outlook (RTTNews)
09.05.23	Perrigo Company plc Q1 Earnings Summary (RTTNews)
09.05.23	Perrigo Reports First Quarter Fiscal Year 2023 Financial Results From Continuing Operations (PR Newswire)
06.04.23	Firefly® Expands Its Commitment to Sustainability with Free Recycling Program (PR Newswire)
28.03.23	Perrigo: FDA Reschedules Joint Meeting Of NDAC, And ORUDAC To Review Application For Opill OTC Use (RTTNews)
01.03.23	Perrigo : FDA Approves Store Brand OTC Equivalent Of Advil Dual Action Tablets (RTTNews)
27.02.23	Perrigo Company plc Q4 Earnings Summary (RTTNews)
27.02.23	Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations (PR Newswire)
08.11.22	Perrigo Updates FY22 Adj. EPS Outlook; Reiterates Organic Sales Growth Outlook (RTTNews)
08.11.22	Perrigo Company plc Q3 Earnings Summary (RTTNews)
08.11.22	Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operations (PR Newswire)
08.11.22	Form 8-K 1585364 (RSS)
01.11.22	Perrigo Announces Strategic Investment to Expand and Strengthen U.S. Manufacturing of Infant Formula (PR Newswire)
26.10.22	Perrigo: FDA Postpones Meeting To Review Additional Information Requested Related To Opill (RTTNews)
26.10.22	Biotech Stocks Facing FDA Decision In November 2022 (RTTNews)
12.09.22	Perrigo: FDA Schedules Joint Advisory Committee Meeting To Review Application For Opill For OTC Use (RTTNews)
09.08.22	Perrigo Expects To Achieve FY22 Constant Currency Adj. EPS Range Outlook (RTTNews)
09.08.22	Perrigo Company plc Q2 Earnings Summary (RTTNews)
09.08.22	PERRIGO REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS (PR Newswire)
09.08.22	Current report (RSS)
03.08.22	Initial statement of beneficial ownership of securities (RSS)
11.07.22	Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S. (RTTNews)
09.06.22	Initial statement of beneficial ownership of securities (RSS)
11.05.22	Perrigo Company plc Q1 Earnings Summary (RTTNews)
11.05.22	Perrigo Company Names Eduardo Bezerra CFO - Quick Facts (RTTNews)
11.05.22	PERRIGO REPORTS FIRST QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS, RAISES GUIDANCE (PR Newswire)
28.04.22	Form 8-K 1585364 (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	309.10	2.90 %	K V
Holcim	90.66	2.49 %	K V
Part Grp Hldg	1’227.00	1.49 %	K V
Lonza Grp	521.20	1.48 %	K V
Swiss Life Hldg	726.60	1.37 %	K V
Alcon	75.88	0.37 %	K V
Nestle	76.92	0.34 %	K V
Novartis	91.29	0.25 %	K V
Givaudan	3’876.00	0.16 %	K V
Kuehne+Nagel Int	210.50	0.05 %	K V

mehr

21.10.24		S&P 500 aktuell: S&P 500 gibt nach
30.09.24		Handel in New York: S&P 500 fällt nachmittags
09.08.24		Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge
09.08.24		Gewinne in New York: S&P 500-Börsianer greifen zu
09.08.24		Verluste in New York: S&P 500 fällt am Mittag zurück
06.08.24		Pluszeichen in New York: S&P 500 mittags fester
05.08.24		Handel in New York: S&P 500 verbucht schlussendlich Verluste
11.06.24		Pluszeichen in New York: S&P 500 legt schlussendlich zu

21.10.24

S&P 500 aktuell: S&P 500 gibt nach

30.09.24

Handel in New York: S&P 500 fällt nachmittags

09.08.24

Freundlicher Handel: S&P 500 verbucht schlussendlich Zuschläge

09.08.24

Gewinne in New York: S&P 500-Börsianer greifen zu

09.08.24

Verluste in New York: S&P 500 fällt am Mittag zurück

06.08.24

Pluszeichen in New York: S&P 500 mittags fester